Research Article
Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease
Table 3
Baseline characteristics of participants enrolled in the 4-week beverage trial: study cohort 3.
| | Parameters, mean (SD) | Fructose () | Glucose () | value |
| | Age (years) | 14.6 (2.50) | 13.3 (2.32) | 0.273 | | Male, (%) | 3 (37.5) | 4 (50.0) | 0.614 | | Body weight (kg) | 86.1 (13.3) | 81.3 (15.9) | 0.521 | | BMI -score | 2.32 (0.56) | 2.01 (0.26) | 0.184 | | Hepatic fat (%) | 14.5 (5.73) | 12.1 (4.82) | 0.382 | | ALT (U/L) | 35.1 (20.5) | 31.3 (18.6) | 0.698 | | AST (U/L) | 32.1 (9.76) | 32.9 (7.45) | 0.865 | | Triglycerides (mmol/L) | 161 (111) | 175 (58.5) | 0.768 | | Cholesterol (mmol/L) | 166 (28.8) | 170 (48.8) | 0.836 | | LDL (mmol/L) | 106 (32.5) | 105 (38.6) | 0.967 | | HDL (mmol/L) | 45.1 (9.84) | 45.0 (9.83) | 0.986 | | FFA (mmol/L) | 0.97 (0.24) | 1.16 (0.51) | 0.342 | | Glucose (mmol/L) | 5.46 (0.85) | 4.97 (1.59) | 0.461 | | Insulin (mU/L) | 30.0 (13.7) | 31.4 (30.5) | 0.906 | | HOMA-IR | 7.17 (3.03) | 7.23 (8.28) | 0.985 | | hs-CRP (mg/L) | 4.22 (3.03) | 3.16 (2.54) | 0.242 |
|
|
ALT: alanine aminotransferase; AST: aspartate aminotransferase; LDL: low-density lipoprotein; HDL: high-density lipoprotein; FFA: free fatty acid; HOMA-IR: homeostatic model assessment for insulin resistance index, calculated as fasting glucose (mg/dL) × insulin (µU/L)/405; hs-CRP: high sensitivity C-reactive protein.
|
